Robert McBurney, PHD

HHC Research Dept Symposium Speaker Robert McBurneyRobert McBurney is CEO of the Accelerated Cure Project for Multiple Sclerosis (ACP), a non-profit organization accelerating efforts to cure MS by catalyzing research. Prior to joining ACP, Robert co-founded Optimal Medicine Ltd., a UK company developing systems for optimizing the treatment of mental illness. His former positions include Executive VP of TheraGenetics Ltd.; CSO of BG Medicine, Inc.; CEO of Differential Proteomics, Inc.; and, CEO of Cambridge Neuroscience, Inc. Robert was formerly Assistant Director of the UK Medical Research Council Neuroendocrinology Unit and has held positions at the National Institutes of Health, Cambridge University and the University of New South Wales. He is a director of Optimal Medicine and a Trustee of the F. W. Olin College of Engineering. Robert received BSc and PhD degrees from the University of New South Wales, Australia.


Symposium